CL King Starts Bio-Rad Labs (BIO) at Buy
- Top 10 News for 10/17 - 10/21: Merger Rumors Abound; CEOs Depart; Tesla Kicks Autopilot Up A Notch
- Wall Street ends little changed; Microsoft hits record
- AT&T (T) in Advanced Talks to Acquire Time Warner (TWX) - DJ
- Rockwell Automation (ROK) Said to Attract Takeover Interest from Schneider Electric - Source
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
CL King initiated coverage on Bio-Rad Labs (NYSE: BIO) with a Buy rating and a price target of $180.00.
Shares of Bio-Rad Labs closed at $161.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rodman & Renshaw Starts Abraxas Petroleum (AXAS) at Buy
- UPDATE: Stifel Starts Xenon Pharmaceuticals (XENE) at Buy
- Mitsubishi UFJ Starts Open Text (OTEX) at Overweight
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesCL King
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!